Skip main navigation

Military Health System

Hurricane Milton & Hurricane Helene

Emergency procedures are in place in multiple states due to Hurricane Milton & Hurricane Helene. >>Learn More

Military Medical Officials Back FY 23 Budget Before Senate Appropriations Committee

Image of Marines with Marine Wing Headquarters Squadron, 3rd Marine Aircraft Wing take precautionary measures by cleaning and disinfecting their hands during field day on Marine Corps Air Station Miramar, Calif., March 20, 2020, to mitigate the spread of COVID-19 while continuing to perform mission-essential tasks. (Photo: Marine Corps Lance Cpl. Jaime Reyes). Marines with Marine Wing Headquarters Squadron, 3rd Marine Aircraft Wing take precautionary measures by cleaning and disinfecting their hands during field day on Marine Corps Air Station Miramar, Calif., March 20, 2020, to mitigate the spread of COVID-19 while continuing to perform mission-essential tasks. (Photo: Marine Corps Lance Cpl. Jaime Reyes)

In the past year, the Defense Department has seen significant advances in its medical response to the COVID-19 pandemic within the DOD and in its support of the civilian-sector pandemic, the official performing the duties of assistant secretary of defense for health affairs said before the Senate Appropriations Committee, March 29, 2022. 

Dr. David J. Smith said the National Defense Authorization Act for fiscal year 2017 "enacted sweeping reforms" to the organization and the management of military medicine. 

"We've made significant progress in implementing these reforms," he said, adding "Today, the Defense Health Agency exercises authority, direction and control over all in [military treatment facilities] worldwide. The same law directed the DOD to restructure or realign MTFs as necessary and appropriate to support the department's readiness requirements." 

However, those restructuring efforts will pause April 2 as a result of resources needed to respond to the COVID-19 pandemic, he noted. "But we clearly plan to restart implementation beginning in the first quarter of fiscal year '23 with the targeted completion in September 2026. The department's mission requirements in supporting our national COVID response, however, have adversely affected the defense health program budget in FY 2022," Smith said. 

Despite short-term budgetary challenges, the military health care system continues its sustained, decade-long track record of responsibly managing health care costs, which remain below the national health expenditures per capita rate, he said. "And the department continues to pursue opportunities for greater effectiveness and efficiency by fully integrating the operation of our medical services and streamlining internal operations." 

To sustain momentum and prepare for future pandemics, the DOD's future medical budget will support pandemic readiness and response in the MHS by enhancing its capabilities to conduct rapid research and medical countermeasure development — such as diagnostics, treatments and vaccines — while strengthening the capability of the department to quickly identify and characterize new variants and other emerging biologic threats, Smith noted. 

"Our FY 2023 budget will present a balanced, comprehensive strategy that aligns with the [Secretary of Defense's] priorities, to include ongoing response to the COVID-19 pandemic. We look forward to working with you over the coming months to further refine and articulate our requirements," he told the committee. 

Army Lt. Gen. (Dr.) Ronald J. Place, Defense Health Agency director, focused on some critical responsibilities the DHA has in support of the military departments and combatant commands. 

"The response to the COVID-19 pandemic was one of our top priorities, vital to the medical readiness of our forces in the health and well-being of all Americans," he told the committee. "The department expanded its COVID-19 testing capability and capacity. We have 140 operational laboratories for COVID-19 testing, and we conducted over 6.2 million tests worldwide," he noted. 

The DHA regularly updates its COVID-19 practice management guidelines — which is on version No. 8 — to provide military clinicians and military medical treatment facilities worldwide with a single document on best practices, and the latest evidence and guidance across all clinical care specialties, Place said. 

The DHA also led a comprehensive campaign to administer COVID-19 vaccines. As of March 23, the MHS had administered nearly 8 million doses of COVID-19 vaccines and more than 1.6 million military personnel have been fully vaccinated, he added. 

"Throughout the pandemic, the DOD provided extensive support to [the Federal Emergency Management Agency] for COVID-19 response that included both mass vaccination and health care delivery, augmentation and [aided] communities needing additional personnel resources," he said. 

"We also delivered medical support to the Departments of State and Homeland Security for assisting evacuees from Afghanistan. Our medical teams are proud to contribute to this whole-of-government response to both events and non-COVID activities," Place said. 

The DOD continues to proceed with a multi-year implementation of its new electronic health record, which is dubbed MHS Genesis. It has been deployed at 66 MTFs and more than 1,300 individual locations with more than 93,000 active DOD users of that system, he said, adding, "We will complete the deployment by the end of calendar year 2023 on schedule." 

COVID-19 has only exacerbated these known challenges, Place said. "Nonetheless, we remain vigilant about our medical expenditures. And we appreciate that Congress continues to grant the department carryover authority. Allowing the DOD to maintain better funding flows to minimize disruption of health care services to our beneficiaries." 

You also may be interested in...

Report
Jan 1, 2017

MSMR Vol. 24 No. 2 - February 2017

.PDF | 1.31 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Incident diagnoses of leishmaniasis, active and reserve components, U.S. Armed Forces, 2001–2016; Incidence rates of malignant melanoma in relation to years of military service, overall and in selected ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 3 - March 2017

.PDF | 1.60 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Diagnoses of traumatic brain injury not clearly associated with deployment, active component, U.S. Armed Forces, 2001–2016; Update: Heat illness, active component, U.S. Armed Forces, 2016; Update: Exertional ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 9 - September 2017

.PDF | 1.03 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Review of the U.S. military's human immunodeficiency virus program: a legacy of progress and a future of promise; Update: Routine screening for antibodies to human immunodeficiency virus, civilian applicants ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 8 - August 2017

.PDF | 986.46 KB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Multiple sclerosis among service members of the active and reserve components of the U.S. Armed Forces and among other beneficiaries of the Military Health System, 2007–2016; Challenges with diagnosing and ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 4 - April 2017

.PDF | 1.29 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Absolute and relative morbidity burdens attributable to various illnesses and injuries, active component, U.S. Armed Forces, 2016; Hospitalizations, active component, U.S. Armed Forces, 2016; Ambulatory visits, ...

Report
May 11, 2016

Study Finds Strong Immune Response to HPV Vaccine Among Female Service Members

.PDF | 183.92 KB

A new study of female service members that examined their immune response to a vaccine to combat the sexually transmitted virus that causes cervical cancer showed development of antibodies in 80 to 99 percent of recipients against each of the four strains of the disease.

Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery